Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 15, 2014 - Issue 1-2
Submit an article Journal homepage
348
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis

Petra BergströmInstitute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
,
Malin von OtterIInstitute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
,
Staffan NilssonInstitute of Mathematical Sciences, Department of Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden
,
Ann-Charloth NilssonInstitute of Clinical Neuroscience, Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
,
Michael NilssonInstitute of Neuroscience and Physiology, Centre for Brain Repair and Rehabilitation, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia
,
Peter M. AndersenInstitute of Clinical Neuroscience, Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
,
Ola HammarstenInstitute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
&
Henrik ZetterbergInstitute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden and UCL Institute of Neurology, London, UK
 show all
Pages 130-137 | Received 17 Apr 2013, Accepted 27 Aug 2013, Published online: 08 Oct 2013

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Bo Zhang, Zhiyuan Ma, Biqin Tan & Nengming Lin. (2019) Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung. Expert Opinion on Therapeutic Targets 23:3, pages 241-250.
Read now
Marta Pajares, Natalia Jiménez-Moreno, Ángel J. García-Yagüe, Maribel Escoll, María L. de Ceballos, Fred Van Leuven, Alberto Rábano, Masayuki Yamamoto, Ana I. Rojo & Antonio Cuadrado. (2016) Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy 12:10, pages 1902-1916.
Read now
. (2016) ALSUntangled No. 31: Protandim. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 154-156.
Read now
Nadine Bakkar, Arianna Kousari, Tina Kovalik, Yang Li & Robert Bowser. (2015) RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1. Molecular and Cellular Biology 35:14, pages 2385-2399.
Read now

Articles from other publishers (28)

Aven Lee, Robert Henderson, Buddhika Jayakody Arachchige, Thomas Robertson & Pamela Ann McCombe. (2023) Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms. Journal of the Neurological Sciences 452, pages 120753.
Crossref
John Paul Llido, Sri Jayanti, Claudio Tiribelli & Silvia Gazzin. (2023) Bilirubin and Redox Stress in Age-Related Brain Diseases. Antioxidants 12:8, pages 1525.
Crossref
Lev N. Porokhovnik, Vladimir M. Pisarev, Anastasia G. Chumachenko, Julia M. Chudakova, Elizaveta S. Ershova, Natalia N. Veiko, Natalia L. Gorbachevskaya, Uliana A. Mamokhina, Alexander B. Sorokin, Anna Ya. Basova, Mikhail S. Lapshin, Vera L. L. Izhevskaya & Svetlana V. Kostyuk. (2023) Association of NEF2L2 Rs35652124 Polymorphism with Nrf2 Induction and Genotoxic Stress Biomarkers in Autism. Genes 14:3, pages 718.
Crossref
Hai Duc Nguyen. (2022) Resveratrol, Endocrine Disrupting Chemicals, Neurodegenerative Diseases and Depression: Genes, Transcription Factors, microRNAs, and Sponges Involved. Neurochemical Research 48:2, pages 604-624.
Crossref
Ben Gaastra, Poppy Duncan, Mark K. Bakker, Isabel C. Hostettler, Varinder S. Alg, Henry Houlden, Ynte M. Ruigrok, Ian Galea, Will Tapper, David Werring & Diederik Bulters. (2022) Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage . European Journal of Neurology 30:1, pages 116-124.
Crossref
Mathew George, Matthan Tharakan, John Culberson, Arubala P. Reddy & P. Hemachandra Reddy. (2022) Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases. Ageing Research Reviews 82, pages 101756.
Crossref
Elif Kubat Oktem, Busra Aydin, Metin Yazar & Kazim Yalcin Arga. (2022) Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1G93A Mice Models Uncover Potential Drug Treatments for ALS. Journal of Molecular Neuroscience 72:11, pages 2360-2376.
Crossref
Isabel Lastres-Becker, Eva de Lago, Ana Martínez & Javier Fernández-Ruiz. (2022) New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Biomolecules 12:9, pages 1200.
Crossref
Chenlu Fan, Zaihong Zhan, Xin Zhang, Qun Lou, Ning Guo, Mengyao Su, Yue Gao, Ming Qin, Liaowei Wu, Wei Huang, Meichen Zhang, Fanshuo Yin, Yanhui Wu, Jingbo Pi, Yuanyuan Xu, Yanmei Yang & Yanhui Gao. (2022) Research for type 2 diabetes mellitus in endemic arsenism areas in central China: role of low level of arsenic exposure and KEAP1 rs11545829 polymorphism. Archives of Toxicology 96:6, pages 1673-1683.
Crossref
Alexey V. Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev & Alexander S. Sobolev. (2022) Nrf2/Keap1/ARE signaling: Towards specific regulation. Life Sciences 291, pages 120111.
Crossref
Antonio Cuadrado. (2022) Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases. Annual Review of Pharmacology and Toxicology 62:1, pages 255-277.
Crossref
Stephanie M. Boas, Kathlene L. Joyce & Rita M. Cowell. (2021) The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention. Antioxidants 11:1, pages 8.
Crossref
J. Jiménez-Villegas, L. Ferraiuolo, R.J. Mead, P.J. Shaw, A. Cuadrado & A.I. Rojo. (2021) NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. Free Radical Biology and Medicine 173, pages 125-141.
Crossref
Antonela Matana, Panos G. Ziros, Dionysios V. Chartoumpekis, Cedric O. Renaud, Ozren Polašek, Caroline Hayward, Tatijana Zemunik & Gerasimos P. Sykiotis. (2020) Rare and common genetic variations in the Keap1/Nrf2 antioxidant response pathway impact thyroglobulin gene expression and circulating levels, respectively. Biochemical Pharmacology 173, pages 113605.
Crossref
Antonio Cuadrado, Ana I. Rojo, Geoffrey Wells, John D. Hayes, Sharon P. Cousin, William L. Rumsey, Otis C. Attucks, Stephen Franklin, Anna-Liisa Levonen, Thomas W. Kensler & Albena T. Dinkova-Kostova. (2019) Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery 18:4, pages 295-317.
Crossref
Chiara F. Valori, Giulia Guidotti, Liliana Brambilla & Daniela Rossi. 2019. Neuroglia in Neurodegenerative Diseases. Neuroglia in Neurodegenerative Diseases 227 272 .
Umapathy Dhamodharan, Balashanmugam Ponjayanthi, Dornadula Sireesh, Elango Bhakkiyalakshmi & Kunka Mohanram Ramkumar. (2018) Association of single-nucleotide polymorphisms of the KEAP1 gene with the risk of various human diseases and its functional impact using in silico analysis. Pharmacological Research 137, pages 205-218.
Crossref
Ana I. Rojo, Marta Pajares, Angel J. García-Yagüe, Izaskun Buendia, Fred Van Leuven, Masayuki Yamamoto, Manuela G. López & Antonio Cuadrado. (2018) Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy. Redox Biology 18, pages 173-180.
Crossref
Pablo Ranea‐Robles, Nathalie Launay, Montserrat Ruiz, Noel Ylagan Calingasan, Magali Dumont, Alba Naudí, Manuel Portero‐Otín, Reinald Pamplona, Isidre Ferrer, M Flint Beal, Stéphane Fourcade & Aurora Pujol. (2018) Aberrant regulation of the GSK ‐3β/ NRF 2 axis unveils a novel therapy for adrenoleukodystrophy . EMBO Molecular Medicine 10:8.
Crossref
Antonio Cuadrado, Gina Manda, Ahmed Hassan, María José Alcaraz, Coral Barbas, Andreas Daiber, Pietro Ghezzi, Rafael León, Manuela G. López, Baldo Oliva, Marta Pajares, Ana I. Rojo, Natalia Robledinos-Antón, Angela M. Valverde, Emre Guney & Harald H. H. W. Schmidt. (2018) Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacological Reviews 70:2, pages 348-383.
Crossref
L. N. Porokhovnik & V. M. Pisarev. (2017) Association of polymorphisms in NFE2L2 gene encoding transcription factor Nrf2 with multifactorial diseases. Russian Journal of Genetics 53:8, pages 851-864.
Crossref
Л.Н. Пороховник & В.М. Писарев. (2017) СВЯЗЬ АЛЛЕЛЬНЫХ ВАРИАНТОВ ГЕНА ТРАНСКРИПЦИОННОГО ФАКТОРА Nrf2 С ПАТОГЕНЕЗОМ МНОГОФАКТОРНЫХ ЗАБОЛЕВАНИЙ, "Генетика". Генетика:8, pages 895-910.
Crossref
Caroline Ran, Karin Wirdefeldt, Lovisa Brodin, Mehrafarin Ramezani, Marie Westerlund, Fengqing Xiang, Anna Anvret, Thomas Willows, Olof Sydow, Anders Johansson, Dagmar Galter, Per Svenningsson & Andrea Carmine Belin. (2017) Genetic Variations and mRNA Expression of NRF2 in Parkinson’s Disease. Parkinson's Disease 2017, pages 1-7.
Crossref
Antonio Cuadrado. (2016) NRF2 in neurodegenerative diseases. Current Opinion in Toxicology 1, pages 46-53.
Crossref
Alice Goode, Sarah Rea, Melanie Sultana, Barry Shaw, Mark S. Searle & Robert Layfield. (2016) ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Molecular and Cellular Neuroscience 76, pages 52-58.
Crossref
Delinda A. Johnson & Jeffrey A. Johnson. (2015) Nrf2—a therapeutic target for the treatment of neurodegenerative diseases. Free Radical Biology and Medicine 88, pages 253-267.
Crossref
Hye-Youn Cho, Jacqui Marzec & Steven R. Kleeberger. (2015) Functional polymorphisms in Nrf2: implications for human disease. Free Radical Biology and Medicine 88, pages 362-372.
Crossref
Zhou Liu, Xiaojian Yin, Lingying Liu, Hua Tao, Haihong Zhou, Guoda Ma, Lili Cui, You Li, Shuyan Zhang, Zhi'en Xu, LiFen Yao, Zhiyou Cai, Bin Zhao & Keshen Li. (2015) Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy. Gene 571:2, pages 231-236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.